353 related articles for article (PubMed ID: 28709694)
1. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R
J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694
[TBL] [Abstract][Full Text] [Related]
2. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic.
Thompson AK; Killian JM; Weaver AL; Pittelkow MR; Davis MD
J Am Acad Dermatol; 2017 Apr; 76(4):683-688. PubMed ID: 28012574
[TBL] [Abstract][Full Text] [Related]
3. Sézary syndrome without erythroderma.
Henn A; Michel L; Fite C; Deschamps L; Ortonne N; Ingen-Housz-Oro S; Marinho E; Beylot-Barry M; Bagot M; Laroche L; Crickx B; Maubec E
J Am Acad Dermatol; 2015 Jun; 72(6):1003-9.e1. PubMed ID: 25981000
[TBL] [Abstract][Full Text] [Related]
4. Sézary syndrome without erythroderma: A case report and review of published work.
Kamijo H; Miyagaki T; Norimatsu Y; Shishido-Takahashi N; Kuzumi A; Asano Y; Sato S
J Dermatol; 2019 Jan; 46(1):61-64. PubMed ID: 30379353
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
Sentis HJ; Willemze R; Scheffer E
J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
[TBL] [Abstract][Full Text] [Related]
6. Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
Pileri A; Pellegrini C; Agostinelli C; Grandi V; Patrizi A; Zinzani PL; Pimpinelli N
Eur J Dermatol; 2017 Feb; 27(1):49-53. PubMed ID: 27873737
[TBL] [Abstract][Full Text] [Related]
7. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
8. [A patient with erythroderma and pruritus: Sézary syndrome].
Overweel AFP; Langerak AW; Damman J; de Haas ELM; Weerkamp F; Sandberg Y
Ned Tijdschr Geneeskd; 2022 Feb; 166():. PubMed ID: 35499588
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
[TBL] [Abstract][Full Text] [Related]
10. Pre-Sézary erythroderma evolving to Sézary syndrome. A report of seven cases.
Buechner SA; Winkelmann RK
Arch Dermatol; 1983 Apr; 119(4):285-91. PubMed ID: 6220677
[TBL] [Abstract][Full Text] [Related]
11. Sézary cell count in exfoliative dermatitis.
Duangurai K; Piamphongsant T; Himmungnan T
Int J Dermatol; 1988 May; 27(4):248-52. PubMed ID: 2968960
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides and sezary syndrome: an update.
Kim EJ; Lin J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Curr Oncol Rep; 2006 Sep; 8(5):376-86. PubMed ID: 16901399
[TBL] [Abstract][Full Text] [Related]
13. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
14. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
15. A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.
Luherne C; Menguy S; Ferte T; Beylot-Barry M; Seneschal J; Milpied B; Vial JP; Gros A; Amintas S; Vergier B; Pham-Ledard A
Acta Derm Venereol; 2022 Sep; 102():adv00773. PubMed ID: 35758515
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study.
Marchetti MA; Pulitzer MP; Myskowski PL; Dusza SW; Lunning MA; Horwitz SM; Moskowitz AJ; Querfeld C
J Am Acad Dermatol; 2015 Feb; 72(2):293-301. PubMed ID: 25455841
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic erythroderma: a follow-up study of 28 patients.
Sigurdsson V; Toonstra J; van Vloten WA
Dermatology; 1997; 194(2):98-101. PubMed ID: 9094454
[TBL] [Abstract][Full Text] [Related]
18. Heteroduplex analysis of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for erythroderma.
Cherny S; Mraz S; Su L; Harvell J; Kohler S
J Cutan Pathol; 2001 Aug; 28(7):351-5. PubMed ID: 11437940
[TBL] [Abstract][Full Text] [Related]
19. Benign and malignant forms of erythroderma: cutaneous immunophenotypic characteristics.
Abel EA; Lindae ML; Hoppe RT; Wood GS
J Am Acad Dermatol; 1988 Dec; 19(6):1089-95. PubMed ID: 2974461
[TBL] [Abstract][Full Text] [Related]
20. CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome.
Ortonne N; Le Gouvello S; Mansour H; Poillet C; Martin N; Delfau-Larue MH; Leroy K; Farcet JP; Bagot M; Bensussan A
J Invest Dermatol; 2008 Feb; 128(2):465-72. PubMed ID: 17703174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
